Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral T-cell lymphoma in Japan: recent progress.

M Shimoyama1

  • 1Hematology-Oncology and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|February 1, 1991
PubMed
Summary

Adult T-cell leukemia-lymphoma (ATL) is a significant subset of non-Hodgkin's lymphoma, often linked to HTLV-I. Distinct subtypes of T-lymphoma require specific terminology due to differing prognoses and origins.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prevalence of mental health problems in adults with intellectual disabilities in Japan, associated factors and mental health service use.

Journal of intellectual disability research : JIDR·2018
Same author

The Differences between Lymphoma and Leukemia Type of Adult T-cell Leukemia.

Leukemia & lymphoma·2016
Same author

Retrospective evaluation of the effect of carotid artery stenosis on cerebral oxygen saturation during off-pump coronary artery bypasses grafting in adult patients.

BMC anesthesiology·2015
Same author

Perfusion index derived from a pulse oximeter can predict the incidence of hypotension during spinal anaesthesia for Caesarean delivery.

British journal of anaesthesia·2013
Same author

Gene Ontology annotations and resources.

Nucleic acids research·2012
Same author

Goal-directed fluid therapy in patients undergoing colorectal surgery.

British journal of anaesthesia·2012

Area of Science:

  • Hematology
  • Oncology
  • Virology

Background:

  • T-cell lymphomas, including adult T-cell leukemia-lymphoma (ATL), represent a substantial proportion of non-Hodgkin's lymphoma cases in Japan.
  • While Human T-cell leukemia/lymphoma virus type I (HTLV-I) is strongly associated with ATL, a notable percentage of ATL patients are HTLV-I negative.
  • Immunoblastic lymphadenopathy (IBL)-like T-lymphoma is a recognized entity within T-cell malignancies.

Purpose of the Study:

  • To differentiate between ATL, peripheral non-ATL T-lymphoma, and B-lymphoma based on distinct clinical, etiological, and prognostic factors.
  • To investigate the potential multi-step leukemogenesis of ATL, possibly involving the accumulation of somatic mutations in HTLV-I-infected T-cells.
  • To highlight the inadequacy of the general term 'non-Hodgkin's lymphoma' for T-cell malignancies due to significant variations.

Related Experiment Videos

Main Methods:

  • Statistical modeling (Weibull model) to analyze the cumulative incidence of anti-HTLV-I seropositive ATL patients.
  • Morphological and immunophenotypic analysis for diagnosing T-cell lymphomas, including identification of atypical neoplastic cells and immunoblasts.
  • Comparative analysis of prognostic factors, treatment outcomes, and etiological differences across ATL, peripheral non-ATL T-lymphoma, and B-lymphoma.

Main Results:

  • The incidence of anti-HTLV-I seropositive ATL suggests a multi-event process, potentially involving around five critical genetic events.
  • Peripheral non-ATL T-lymphoma and B-lymphoma respond similarly to standard chemotherapy, contrasting with the challenging treatment of ATL.
  • Prognostic factors and treatment outcomes vary significantly among ATL, peripheral non-ATL T-lymphoma, and B-lymphoma, underscoring their distinct disease entities.

Conclusions:

  • ATL, peripheral non-ATL T-lymphoma, and B-lymphoma should be classified separately due to fundamental differences in cellular origin, clinical presentation, and prognosis.
  • Accurate pathological diagnosis, recognizing specific cellular morphology, is crucial for appropriate patient management and outcome prediction.
  • The distinct characteristics of these lymphoma subtypes necessitate tailored therapeutic strategies and further research into their specific etiologies and pathogenesis.